Company

Nanology Labs Inc.

Nanology Labs develops delivery technologies for biological therapeutics.

About

Nanology Labs develops controlled-release delivery technologies for biological therapeutics, including monoclonal antibodies and gene therapies. It serves pharmaceutical and biotechnology companies. Founded in 2018 and based in Toronto, the company raised USD 3.000 mn in Seed funding in May 2021 to develop T-MX, a nanomedicine for tumor hypoxia.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in